JP2024534427A5 - - Google Patents
Info
- Publication number
- JP2024534427A5 JP2024534427A5 JP2024516849A JP2024516849A JP2024534427A5 JP 2024534427 A5 JP2024534427 A5 JP 2024534427A5 JP 2024516849 A JP2024516849 A JP 2024516849A JP 2024516849 A JP2024516849 A JP 2024516849A JP 2024534427 A5 JP2024534427 A5 JP 2024534427A5
- Authority
- JP
- Japan
- Prior art keywords
- milbexian
- use according
- pharmaceutically acceptable
- acceptable salt
- daily dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245522P | 2021-09-17 | 2021-09-17 | |
| US63/245,522 | 2021-09-17 | ||
| US202163278582P | 2021-11-12 | 2021-11-12 | |
| US63/278,582 | 2021-11-12 | ||
| PCT/US2022/043797 WO2023043999A1 (en) | 2021-09-17 | 2022-09-16 | Milvexian for prevention and treatment of thromboembolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534427A JP2024534427A (ja) | 2024-09-20 |
| JP2024534427A5 true JP2024534427A5 (cg-RX-API-DMAC7.html) | 2025-09-25 |
Family
ID=83688923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516849A Pending JP2024534427A (ja) | 2021-09-17 | 2022-09-16 | 血栓塞栓性障害を予防かつ治療するためのミルベキシアン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250099466A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4401736A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534427A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240060820A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022345862A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3232633A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2024000776A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL310894A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024002857A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202327607A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023043999A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4565231A1 (en) * | 2022-08-01 | 2025-06-11 | Bristol-Myers Squibb Company | Use of milvexian for treating or preventing ischemic stroke |
| CN121001727A (zh) * | 2023-04-19 | 2025-11-21 | 百时美施贵宝公司 | 米尔维仙(milvexian)于治疗及预防患有心血管或脑血管疾病的患者的血栓病况的用途 |
| CN121443289A (zh) * | 2023-04-19 | 2026-01-30 | 百时美施贵宝公司 | 米尔维仙在治疗或预防患有急性冠状动脉综合征的患者的不良脑血管事件或不良心血管事件中的用途 |
| CN121398811A (zh) * | 2023-04-19 | 2026-01-23 | 百时美施贵宝公司 | 米尔维仙于治疗及预防患有心房颤动的患者的血栓病况的用途 |
| WO2025126240A1 (en) * | 2023-12-12 | 2025-06-19 | Dr. Reddy's Laboratories Limited | Pharmaceutical compositions and use thereof |
| WO2026115567A1 (en) * | 2024-11-26 | 2026-06-04 | Dr. Reddy’S Laboratories Limited | Sustained release formulations of milvexian |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453018B2 (en) * | 2014-10-01 | 2016-09-27 | Bristol-Myers Squibb Company | Pyrimidinones as factor XIa inhibitors |
| KR20210151183A (ko) | 2019-04-11 | 2021-12-13 | 브리스톨-마이어스 스큅 컴퍼니 | 치료 혈장 농도를 달성하기 위한 무정형 고체 및 가용화된 제제의 증진된 성능 |
-
2022
- 2022-09-16 JP JP2024516849A patent/JP2024534427A/ja active Pending
- 2022-09-16 IL IL310894A patent/IL310894A/en unknown
- 2022-09-16 KR KR1020247012366A patent/KR20240060820A/ko active Pending
- 2022-09-16 MX MX2024002857A patent/MX2024002857A/es unknown
- 2022-09-16 AU AU2022345862A patent/AU2022345862A1/en active Pending
- 2022-09-16 TW TW111135090A patent/TW202327607A/zh unknown
- 2022-09-16 CA CA3232633A patent/CA3232633A1/en active Pending
- 2022-09-16 WO PCT/US2022/043797 patent/WO2023043999A1/en not_active Ceased
- 2022-09-16 EP EP22786640.7A patent/EP4401736A1/en active Pending
- 2022-09-16 US US18/692,560 patent/US20250099466A1/en active Pending
-
2024
- 2024-03-15 CL CL2024000776A patent/CL2024000776A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL310894A (en) | Milovacian for the prevention and treatment of thromboembolic disorders | |
| AU2018357775B2 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD) | |
| JP2017510607A5 (cg-RX-API-DMAC7.html) | ||
| CN107519159A (zh) | 复方组合物 | |
| JP2023535744A5 (cg-RX-API-DMAC7.html) | ||
| JP2023552700A5 (cg-RX-API-DMAC7.html) | ||
| JP2022550919A5 (cg-RX-API-DMAC7.html) | ||
| HRP20251043T1 (hr) | Novi oralni farmaceutski pripravak i režim doziranja za terapiju progresivnih fibrozirajućih intersticijskih bolesti pluća | |
| JP2023526754A5 (cg-RX-API-DMAC7.html) | ||
| JP2021532171A5 (cg-RX-API-DMAC7.html) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2016505050A5 (cg-RX-API-DMAC7.html) | ||
| MX2022012693A (es) | Composicion que comprende metilfolato. | |
| JP2024540439A5 (cg-RX-API-DMAC7.html) | ||
| JP2024531799A5 (cg-RX-API-DMAC7.html) | ||
| JP2024520690A5 (cg-RX-API-DMAC7.html) | ||
| JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および/または症状軽減剤 | |
| US9545419B1 (en) | Method and compositions for treating chronic inflammatory disorders | |
| JP2024527175A5 (cg-RX-API-DMAC7.html) | ||
| US20110117070A1 (en) | Compositions and methods for treating headache | |
| CN108472375A (zh) | 中重度流感的治疗方法 | |
| JP2022504435A5 (cg-RX-API-DMAC7.html) | ||
| JP2017511307A5 (cg-RX-API-DMAC7.html) | ||
| IL319025A (en) | Methods for treating or preventing endometriosis | |
| JP2021521227A5 (cg-RX-API-DMAC7.html) |